Stanford Dermatology
Redwood City, California, 94603, United States
NCT Number: NCT02749786
Rosacea is a common disease characterized by inflammation and vascular abnormalities of the facial skin and ocular surface. It it considered to be a syndrome encompassing various combinations of cutaneous signs including flushing, erythema, telangiectasia, papules, edema, ocular lesions, and rhinophyma. The exact etiology of cutaneous rosacea is unknown but is characterized by persistent vasodilation, increased vascular permeability, and vascular hyper-reactivity of the microcirculation of the central part of the face. The purpose of this study is to develop gene expression profiles of papulopustular rosacea compared to those of normal skin. The investigator hopes to better understand the abnormal gene functions that might contribute to this condition. This understanding may lead to the development of additional and better treatments for rosacea.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Redwood City, California, 94603, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
include:
Exclusion criteria
include:
Skin biopsies will be performed via the Keys punch technique from normal facial skin.
Time frame: Up to 2 years
Stanford University
Other
Expansion Arm of Papulopustular Rosacea Gene Expression Profiling to Include Normal Individuals as Anatomic Site Specific Controls
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07729540
Erythema, Pathological Conditions, Signs and Symptoms
Sosnowiec, Poland
View Trial DetailsNCT07606820
Rosacea, Skin Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT04886739
Rosacea, Skin Diseases
Fremont, California, United States
View Trial DetailsNCT04275999
Rosacea, Skin Diseases
Winston-Salem, North Carolina, United States
View Trial Details